Strategic partnership set to transform urine testing

Alpha Laboratories Ltd is excited to announce a strategic partnership with Clinical Design Technologies Ltd to market and support the world's first digital closed urine testing system. This ground-breaking innovation sets a new benchmark for urinalysis at the point of care, offering exceptional clinical efficacy, simplicity, and accuracy.

The Clinical Design Technologies UTS™ (Urine Testing System) is engineered to deliver rapid, Right First Time™ urinalysis results, streamlining the testing process for healthcare professionals. Its advanced design ensures precise and reliable data, empowering informed decision-making, enhancing clinical outcomes, and optimising resource allocation. This not only improves patient care across various pathways but also reduces costs and frees up valuable healthcare resources.

"We are delighted to join forces with Clinical Design Technologies to introduce this pioneering solution to our clinical customers and new markets," said Rob Vint, Managing Director of Alpha Laboratories. "The UTS™ system represents a major leap forward in urinalysis, offering unmatched accuracy and efficiency at the point of care."

"This partnership with Alpha Laboratories marks a significant milestone in urine testing," added Daniel Bee, CEO of Clinical Design Technologies. "By leveraging Alpha’s highly respected market presence, our advanced diagnostic technology will reach a broader spectrum of patients, from acute to community care. The simplicity and accuracy of the UTS™ system will enhance clinical productivity, reduce costs, and improve the efficiency of healthcare services, ultimately benefiting patients."

This collaboration between two leading British diagnostic companies promises to revolutionise urine testing, driving improvements in clinical practice and patient outcomes across the UK and beyond.

More information online